A narrative review highlights the importance of recognizing “borderline resectable colorectal liver metastases” (br-crlm) as a distinct entity. By analyzing criteria for resectability, researchers found a significant need for chemotherapy prior to surgery. Advances in surgical techniques, locoregional therapies, and perioperative chemotherapy have improved long-term survival outcomes for patients with br-crlm undergoing treatment. The current literature shows considerable heterogeneity, emphasizing the necessity for consensus in defining and managing these cases.
Review by Varty GP, Patkar S (…) Goel M et 2 al. in J Gastrointest Surg
Copyright © 2024 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.